Rivoxa 10, 15 & 20 10, 15 & 20 mg FC Tablet
PDF Leaflet Revision Date: 28 November 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Prevention of VTE and treatment of DVT/PE.
Dosage (summary)
RIVOXA 10: 10 mg once daily; RIVOXA 15: 15 mg once daily; RIVOXA 20: 20 mg once daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- Other anticoagulants
- NSAIDs
Contraindications
- Active bleeding
- Severe hepatic disease
- Hypersensitivity
Common side effects
- Anaemia
- Dizziness
- Haematoma
- Gastrointestinal bleeding
Counselling Points
- Take with food for RIVOXA 15 and 20
- Monitor for bleeding signs
- Do not double doses if missed
Serious warnings
- Increased bleeding risk
- Monitor for signs of bleeding
Important Disclaimer
The Rivoxa 10, 15 & 20 10, 15 & 20 mg FC Tablet professional information leaflet below is the property of Abex Pharmaceutica and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
